Curaxis Pharmaceutical Corp. (ASCH.OB) Issues Optimistic View and Update on Alzheimer Drug Candidate
Curaxis Pharmaceutical Corp. today offered an update on its clinical development plans for Memryte, its candidate to treat mild-to-moderate Alzheimer's…